Benralizumab
Name: Benralizumab
Pronunciation
(ben ra LIZ ue mab)
Index Terms
- Fasenra
Brand Names U.S.
- Fasenra
Use Labeled Indications
Asthma: Add-on maintenance treatment of severe asthma in adults and children ≥12 years of age with an eosinophilic phenotype
Limitations of use: Not indicated for treatment of other eosinophilic conditions or for the relief of acute bronchospasm or status asthmaticus
Contraindications
Hypersensitivity to benralizumab or any component of the formulation